Prosecutors seeking 15 years behind bars for Theranos CEO Elizabeth Holmes


Federal prosecutors are recommending a sentence of 15 years in prison for disgraced Theranos founder Elizabeth Holmes, Reuters reported Friday.
Holmes, 38, was found guilty this past January of defrauding investors about the merits of Theranos' blood-testing machines. She is facing a maximum of 20 years in prison, though experts predicted her actual sentence would likely be shorter.
In addition to the recommended sentence, U.S. attorneys said Holmes should be forced to pay $800 million in restitution to investors, per Reuters.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Holmes is scheduled to be sentenced next week, and her time in prison will be the final domino to fall in one of the largest investment fraud schemes in American history, as well as one of the most notable falls from grace in tech history. Forbes had at one point named Holmes the youngest self-made female billionaire in the country, and Theranos had an estimated valuation of $9 billion.
However, an investigation by The Wall Street Journal soon revealed that Holmes and other top officials at Theranos had lied to investors about the accuracy and capabilities of their blood-testing machines. As the investigation grew to involve the federal government, Theranos' value soon plunged to zero, and the SEC soon charged Holmes with "massive fraud" related to her running of the company.
According to reports from The Associated Press and Bloomberg, Holmes is seeking an 18-month house arrest sentence in lieu of prison time. However, it was noted that, given the scope of her crimes, this request was unlikely to be granted.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
DHS preps for major ICE expansion, rankling local law enforcement
IN THE SPOTLIGHT As the Trump administration positions ICE as the primary federal police force, its recruitment efforts have been met with a less-than-enthusiastic response
-
The return of 'Wednesday,' an 'Alien' prequel and a dramatic retelling of the Amanda Knox trial all happening in August TV
the week recommends This month's new television releases include 'Alien: Earth,' 'The Twisted Tale of Amanda Knox' and a new season of 'Wednesday'
-
How does a 401(k) hardship withdrawal work and is it smart to take one?
the explainer More Americans than ever are resorting to this option in a pinch
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Forever chemicals were found in reusable menstrual products. That is nothing new for women.
Under the Radar Toxic chemicals are all too common in such products
-
Scientists are developing artificial blood for use in emergencies
Under the radar It could aid in global blood shortages
-
Babies born using 3 people's DNA lack hereditary disease
Under the Radar The method could eliminate mutations for future generations
-
Not just a number: how aging rates vary by country
The explainer Inequality is a key factor
-
Children's health has declined in the US
The Explainer It's likely a sign of larger systemic issues
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system